Impact of the COVID-19 pandemic and COVID-19 downgrade on non-COVID-19 respiratory diseases in Japan
Although hospitalisations for pneumonia and prescriptions for anti-asthma drugs increased immediately after downgrading COVID-19, no step increase in mortality was observed presumably because older people were less affected than children.
Authors
- Satoko Yamaguchi (ORCID: https://orcid.org/0000-0003-2822-2281)
- Akira Okada (ORCID: https://orcid.org/0000-0001-6480-3388)
- Toshimasa Yamauchi (ORCID: https://orcid.org/0000-0003-4827-6404)
- Masaomi Nangaku (ORCID: https://orcid.org/0000-0001-7401-2934)
- Takashi Kadowaki (ORCID: https://orcid.org/0000-0002-5428-3582)
- Kayo Ikeda Kurakawa
- Sachiko Ono (ORCID: https://orcid.org/0000-0003-4378-2578)
- Daisuke Inoue (ORCID: https://orcid.org/0009-0005-5842-2147)
- Shinji Sunaga
Institutions
- University of Tokyo Hospital (JP)
- Toranomon Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Public Health
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1016/j.puhe.2025.03.031
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare